Clexane and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are female, 40-49 old, also take Movicol, and have Agranulocytosis.

The phase IV clinical study analyzes which people have Hyperventilation when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Hyperventilation?

Hyperventilation is found to be associated with 750 drugs and 1,442 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Jun, 13, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 30 people (0.21%) have Hyperventilation.

Among these 30 people:

What is the gender of people who have Hyperventilation when taking Clexane? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperventilation when taking Clexane? *

What are other drugs people take besides Clexane? *

What are other side effects people have besides Hyperventilation? *

Nausea (feeling of having an urge to vomit): 24 people, 80.00%
Dyspnea (difficult or laboured breathing): 20 people, 66.67%
Urinary Tract Infection: 17 people, 56.67%
Inflammation: 17 people, 56.67%
Swallowing Difficulty: 17 people, 56.67%
Fever: 17 people, 56.67%
Fatigue (feeling of tiredness): 17 people, 56.67%
Speech Disorder: 17 people, 56.67%
General Physical Health Deterioration (weak health status): 16 people, 53.33%
Loss Of Consciousness: 16 people, 53.33%

What are the existing conditions these people have? *

Pneumonia: 12 people, 40.00%
Pain: 12 people, 40.00%
Hodgkin's Lymphoma (cancer originating from white blood cells): 12 people, 40.00%
High Blood Pressure: 12 people, 40.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 12 people, 40.00%
Pain In Extremity: 11 people, 36.67%
Back Pain: 9 people, 30.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 26.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 16.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (750 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,442 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.